Skip to main content
. Author manuscript; available in PMC: 2009 Dec 2.
Published in final edited form as: Pharm Dev Regul. 2003 Jan 1;1(3):191–203. doi: 10.1901/jaba.2003.1-191

Table II.

Tracking license compliance: questions to be asked when reviewing a completed license agreement

Are the royalty payments up-to-date and accurate?
Are the progress reports up-to-date?
Have the performance benchmarks been met?
Have new patents been issued or existing patents expired?
Has the license expired?
Is the licensee using, hoarding or reselling the technology?
Have any sublicenses been granted?
Is there another potential exclusive licensee?